Microsynth and CLC bio to Collaborate on Servicing the Swiss High-Throughput Sequencing Market
News May 14, 2010
CLC bio has announced its collaboration with the premier Swiss service provider in molecular biology and sequencing, Microsynth, to support the Swiss market of high-throughput sequencing analyzes.
As from now, Microsynth will provide all customers receiving high-throughput sequencing data with a license for CLC Genomics Workbench for assembly and downstream sequence analyzes.
CEO at Microsynth, Dr. Tobias Schmidheini, states, "Our activities within high-throughput sequencing are growing rapidly and we have been looking for some time for the best way to further support our high-throughput sequencing customers. Establishing a partnership with CLC bio empowers our customers by giving them access to the most user-friendly solution and an excellent cross-platform software for analyzing high-throughput sequencing data in the market."
Director of EMEA Sales at CLC bio, Dr. Michel Seidelin, continues, "Microsynth is a prominent provider of sequencing and related services in Europe and has strong relationships with long-term customers, especially in Austria, Germany, and Switzerland. With their vast experience within the field of DNA sequencing and molecular biology, Microsynth makes an ideal service partner for CLC bio."
The collaboration entails that Microsynth will provide all its customers with a CLC Genomics Workbench license enabling them to visualize their data and create meaningful biological results with ease and confidence.
Computer scientists at Carnegie Mellon University say neural networks and supervised machine learning techniques can efficiently characterize cells that have been studied using single cell RNA-sequencing (scRNA-seq). This finding could help researchers identify new cell subtypes and differentiate between healthy and diseased cells.